Stirling Products (ASX:STI) advises shareholders it has signed an agreement in principle with the private Western Australian company Cocky Smart Pty Ltd for the Australian and international rights to its novel parasiticide for the prevention of flies and ticks primarily with applications in livestock.
Stirling Products Limited (ASX:STI), an animal healthcare development and commercialization company, today announced that it is launching its presence into the companion animal healthcare market at the BIO2008 Annual Convention in San Diego, June 17-20, 2008.
Stirling Products (ASX: STI) advises that its wholly-owned North American subsidiary, Stirling Products North America Inc (STI-NA), has successfully completed product validation trials in shrimp with a leading global animal pharma company for applications for its proprietary immunobiotic ProVale(TM).
Stirling Products (ASX:STI) advises shareholders that it has signed a term sheet with Aquience, a Canadian company, for the exclusive rights to its companion animal product PetQuench(tm), which is already being sold and distributed in North America.
Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary Stirling Products North America Inc. (STI-NA), has signed a Collaboration and Supply Agreement for its lead product ProVale(tm), a highly purified beta glucan.
Stirling Products (ASX: STI) advises that its South African partner, Afgri Limited, has submitted the next stage in the regulatory process towards Act 36 approval.
Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary, Stirling Products North America Inc (STI-NA), has now signed a lease agreement to become the cornerstone tenant in Prince Edward Island's newest commercial BioScience Park facility. STI-NA has signed the lease agreement within the new state of the art two storey 50,000 square foot bio facility.
